Tuesday, October 17, 2017

Wednesday, 5 April 2017Athenaeum InterContinental, Athens

Sponsors

  • ORGANIZED BY

Health Daily is a daily, electronic newsletter, providing its subscribers with reliable and comprehensive information on health and pharma industry in Greece. It includes news for political and financial decisions and evolutions of health, such as healthcare reforms, strategic alliances between pharmaceutical companies, international news etc. In this context, Health Daily organizes a variety of specific conferences for Healthcare Sector such as “The Future of Healthcare in Greece” and the «Patients in Power” Conference.

  • IN COOPERATION WITH

The Pan-Hellenic Union of Pharmaceutical Industry (PEF) represents a total of 40 domestic pharmaceutical manufacturers in Greece. Altogether its members export to more than 85 countries worldwide and conduct over 80 research programs in collaboration with the academia. PEF maintains a workforce of over 10,500 employees, of which 900 are highly skilled researchers and the industry’s annual contribution to the national GDP is estimated at €2.8 billion. PEF's members develop and produce mainly branded generics in more than 27 production units and address all key therapeutic areas in absolute compliance with both EMA and GMP guidelines and quality standards.

SFEE, The Hellenic Association of Pharmaceutical Companies is one of the most innovative, productive and extravert branches of national economy. It represents more than 90% of the pharmaceutical companies active in our country. The 65 member-companies (24 Hellenic and 41 multinational companies), constantly invest in the development of effective medicines and treatments, in order to secure every citizen’s right to health and to a better standard of living.
PIF (Pharma Innovation Forum)
PIF (Pharma Innovation Forum)

PhRMA Innovation Forum represents the biggest pharmaceutical companies in the field of research and biotechnology which support innovation, development and access for Greek patients to safe and effective medicines, creating value for both the Greek economy and society. Members of PIF are:
ABBVIE , AMGEN HELLAS, ASTRAZENECA HELLAS, BAYER HELLAS , BMS HELLAS , CSL BEHRING HELLAS, GENESIS PHARMA, GILEAD SCIENCES, GSK, JANSSEN- CILAG, MERCKSERONO HELLAS, MSD , NOVARTIS HELLAS, NOVO NORDISK HELLAS, PFIZER HELLAS, PHARMASERVE- LILLY , ROCHE HELLAS , SANOFI-AVENTIS, SHIRE HELLAS, UCB

  • GOLD SPONSOR

GE Healthcare invests considerably in the digital age not only through the establishment of a more efficient interconnection between hospital departments and doctors but also through the usage of the data masses provided by its equipment and the cooperation between hardware and software - "digital industry" - to help clinicians make better decisions. Sensors, software and data management converge to improve GE Healthcare's contribution not only in diagnosis but also in pathology, gene sequence and even in tracking of hospital assets. Additionally, we form alliances with leading health institutions, trying to achieve the necessary changes in policy globally, for an effective transition to complete and automatic health care systems. Our vision of the future for health (Healthymagination) invites people to accompany us in our journey as we continuously try to develop innovative services and products at a lower cost, increasing accessibility to medical care while improving quality and effectiveness globally. Based in the United Kingdom, GE Healthcare is a company of the General Electric group (listed in the New York Stock Exchange - NYSE) with a turnover of 17 billion dollars. Throughout the world, GE Healthcare employs more than 46,000 people determined to meet the needs of professionals in the health sector as well as the needs of patients in more than 100 countries.

  • SILVER SPONSORS

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and www.amgen.gr.

At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease, inspires us. We are actively developing treatments for our patients in five important therapeutic areas of healthcare (Oncology, Neuroscience, Immunology, Infectious diseases & vaccines, Cardiovascular & Metabolic diseases).
For more information, please visit us at http://www.janssen.com/greece/.

  • SPONSORS

CSL Behring is a global leader in the plasma protein biotherapeutics industry. We research, develop, manufacture and market biotherapies that are used to treat serious and rare conditions. Users of our therapies rely on them for their quality of life and, in many cases, for life itself. Our commitment to saving lives and improving the quality of life for people with serious and rare conditions is evident in everything we do. Whether we are manufacturing and marketing safe and effective products or researching and developing innovative biotherapies, we are first and foremost focused on fulfilling our customers’ needs.
Learn more on www.cslbehring.gr

Pfizer : Working together for a healthier world
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.
To learn more, please visit us at www.pfizer.gr

  • SUPPORTERS

Aenorasis S.A. is a Greek pharmaceutical company, which has successfully been operating in the healthcare sector since 1998, offering a wide range of effective and innovative diagnostic and therapeutic solutions, in Oncology, Hematology, Nephrology, Rheumatology, Dermatology, Gastroenterology, Gynecology, Cytology, Nuclear Medicine, Anesthesiology and General Surgery.
For further information please visit our website: www.aenorasis.com

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
For more information please visit: www.astrazeneca.gr.

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.
For more information visit: www.merckgroup.com & www.merck.gr.

At Shire, we are champions for people around the world who are struggling with rare diseases – they are at the center of everything we do.
Rare diseases, most of which are genetic and are present throughout a person's entire life, pose a significant medical and economic burden for patients, communities and healthcare systems. There are more than 7,000 known rare diseases, including Hemophilia, Hereditary Angioedema (HAE), Gaucher disease, Hunter Syndrome, and many forms of rare cancer, and an estimated 350 million people worldwide are living with one.

At Siemens Healthineers, we want to make healthcare providers succeed in an ever-changing healthcare industry, by helping them deliver better outcomes at lower costs. Being a leading global healthcare company, with more than 46.000 employees, Siemens Healthineers is continuously developing its portfolio, from medical imaging and laboratory diagnostics, to adding managed services, consulting, and healthcare IT services – as well as further technologies for therapeutic and molecular diagnostics.

  • EXHIBITOR
  • MEDIA SPONSORS
  • INTERPRETING SPONSOR

Communication is more than a right; it is a need and needs know no compromise. Interpretit has arrived to provide interpreting and translation services that meet the needs of modern companies, businessmen and individuals. Professionalism, experience, expertise, flexibility and love for what we do: the key-words describing our ethos and lay the foundations for long-lasting relationships with our clients. Are you ready? Find out more about us on www.interpretit.eu

  • PRESS OFFICE

Become a sponsor

To find out more about your sponsorship benefits contact with with:

Chrisoula Kordouli, tel.: +30 210 661 77 77 (ext. 266), fax: +30 210 661 77 78, e-mail: ckordouli@boussias.com

  • ORGANIZED BY
  • IN COOPERATION WITH
PIF (Pharma Innovation Forum)
PIF (Pharma Innovation Forum)
  • GOLD SPONSOR
  • SILVER SPONSORS
  • SPONSORS
  • SUPPORTERS
  • EXHIBITOR
  • MEDIA SPONSORS
  • INTERPRETING SPONSOR
  • PRESS OFFICE

© 2017 Boussias Communications, all rights reserved. info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team